LX4211, a dual inhibitor of sodium glucose transporters SGLT1 and SGLT2, reduces blood pressure in patients with type 2 diabetesP. Lapuerta, J. Neutel,B. Zambrowicz, I. Ogbaa,P. Banks,K. Frazier,A. SandsDIABETOLOGIA（2013）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
